News About: Pharm. Industry
CTC Bio set eyes on emerging markets
CTC Bio Inc. is going all-out to make inroads into foreign countries to boost the sales of its anti-impotence drug ‘Please pills’ (sildenafil) in oral film.
The company said Monday that it inked an agreement with f...
H2Holdings, Lubo sign MOU for artificial liver
H2Holdings, formerly Hepahope Korea, Monday signed a memorandum of understanding (MOU) with Lubo Industrial Inc., a local supplier for automobile machinery parts, to collaborate on the commercialization of a bio-artif...
Innovative pharmaceutical firms want logo
The Ministry of Health and Welfare announced on June 18 a list of 43 innovative pharmaceutical firms to nurture the selected firms into either of three kinds ― global major pharmaceuticals with more than $10 billion a...
Korean drug makers shy of M&A
Companies could benefit from mergers and acquisitions (M&As) in the changing business environment of the 21st century, but Korean drug firms are still showing a negative attitude towards M&As due to little synergistic...
Binex buys 22% stake in Aprogen
Binex Co. has bought a 22 percent stake in Aprogen from Schnell Biopharmaceuticals for 16 billion won to take lead in biosimilars, industry sources said Wednesday.
Biosimilars, or imitation biopharmaceuticals, are ...
Zytiga approved for metastatic prostate cancer
Janssen Korea said Tuesday that the Korea Food and Drug Administration has approved Zytiga (abiraterone acetate), an oral, once-daily medication for use in combination with prednisone for the treatment of men with met...
Patients call for insurance coverage of Celgene’s multiple myeloma drug
Will multip myeloma patients be able to get cheaper and better drugs this year? Now all eyes are on the government’s decision on the health insurance coverage of Revlimid (lenalidomide), a new drug for multiple myelom...
Pharmaceutical firms vie for new drugs
Korean companies’ zeal toward new drug development is expected to bear fruits as the government has since 2004 backed the pharmaceutical industry as a key growth engine of the next decade, according to the Korean Drug...
LG to supply meningitis vaccine to China
LG Life Sciences Ltd. (LGLS) said Monday that it has signed a contract with Tianjin Pharmaceutical Group Corporation for export of its meningitis vaccine Euhib as a finished form.
Under the deal, both companies wil...
Tasigna vs. Sprycel
Now that Novartis’s Tasigna (nilotinib), another leukemia drug, is now under Korea’s health insurance coverage from July 1 for the treatment of first-line chronic myeloid leukemia, the race has officially begun for tw...
